Human papillomaviruses (HPV) play an etiological role in the development of precancerous and cancerous lesions of the cervix. In Algeria, cervical cancer is currently the second female cancer. This is a real public health problem. It is estimated that approximately 2.3 million women worldwide have invasive cervical cancer. In developing countries, it is the most common cancer in women after breast cancer. The diagnosis is still made most often at advanced stages, which makes the therapeutic results modest and the cost of treatment high. Well-organized cervical cancer screening programs lead to a significant reduction in the incidence and mortality associated with this cancer. Screening is a secondary prevention approach universally considered effective and recommended in most developed countries. While in many developing countries where access to health services is limited, this cancer is the leading cause of death in the female population.